[ad_1]
Recent investment examples show that a successful polio transition in the WHO Eastern Mediterranean Region can provide a high return on investment.
According to the study, preserving polio assets and incorporating them into expanded immunization, surveillance, and emergency response programs could deliver an estimated $289.2 billion worth of economic and social benefits.
The current cost of this work is $7.5 billion, so the return on investment for every dollar spent is nearly $39.
At the 154th meeting of the WHO Executive Board, outgoing WHO Regional Director for the Eastern Mediterranean Region Dr. Ahmed Al Mandhari drew attention to these findings in a press release issued on 14 February 2024. A case to mobilize resources for the long-term sustainability of public health functions, highlighting the economic value and social benefits of preserving polio assets and integrating them into national health systems. Masu. ”
This report provides clear evidence that governments, donors and other stakeholders must now seize the opportunity to leverage these assets to build strong, equitable and resilient health systems. doing.
The report includes data on polio transitions in Iraq, Libya, Somalia, Syrian Arab Republic, Sudan, and Yemen, which have been certified as polio-free, and in Afghanistan and Pakistan, which have not yet been certified.
The Global Polio Eradication Initiative (GPEI) has provided significant technical and financial support to vaccination programs for many years. These capabilities are needed to maintain a polio-free world while building resilience and achieving improved health outcomes.
Polio, or poliomyelitis, is a disease that can cause disability and even death. According to the US CDC, the cause is poliovirus. The virus can spread from person to person, infecting the spinal cord and causing paralysis.
As of February 2024, GPEI has administered more than 1 billion vaccinations with the Novel Type 2 Oral Polio Vaccine (nOPV2).
This new polio vaccine is ‘triple-locked’ using genetic engineering to prevent it from becoming harmful and causing intestinal reactions. As a result, nOPV2 is reported to be more genetically stable than traditional oral polio vaccines.
In the United States, the only vaccine administered since 2000 is the inactivated polio vaccine (IPV). The CDC recommends that children receive four doses of the polio vaccine.
Additionally, the CDC suggests international travelers talk to their health care provider about polio booster options in 2024, depending on their destination.
[ad_2]
Source link
